K. Wyatt Engwall, Director at THERAGENICS CORP (TGX), bought 50,000 shares at $1.35 ($68K) on 2010-02-19, disclosed to the SEC on 2010-02-22.
Open-market purchase of $68k TGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TGX | BUY | 2008-11-07 | $30K | — | Filing → |
| TGX | BUY | 2008-08-28 | $70K | — | Filing → |